Conferences

ecancer travels so that you don't have to. Expore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

IMPAKT Breast Cancer Conference 2013

2 - 4 May 2013
SQUARE Brussels Meeting Centre, Brussels, Belgium
Biomarker analyses in emerging data from PI3K/AKT/mTOR programme clinical trials
Dr Anna Vivancos - Vall d´Hebron Institute of Oncology, Barcelona, Spain
Biomarker analyses in emerging data from PI3K/AKT/mTOR programme clinical trials ( Dr Anna Vivancos - Vall d´Hebron Institute of Oncology, Barcelona, Spain )
16 May 2013
Integrating breast cancer genomics and proteomics
Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA
Integrating breast cancer genomics and proteomics ( Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA )
15 May 2013
Next wave of successful drug therapy strategies in HER2-positive breast cancer
Dr Hans Wildiers - University Hospital Leuven, Gasthuisberg, Belgium
Next wave of successful drug therapy strategies in HER2-positive breast cancer ( Dr Hans Wildiers - University Hospital Leuven, Gasthuisberg, Belgium )
15 May 2013
Genetic and clinical factors best for predicting late recurrence in oestrogen re...
Dr Ivana Sestak - Queen Mary University of London, UK
Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer ( Dr Ivana Sestak - Queen Mary University of London, UK )
15 May 2013
CD4 T cells in extensively inflitrated breast cancer signal organised immune re...
Dr Karen Willard-Gallo - Université Libre de Bruxelles, Brussels, Belgium
CD4  T cells in extensively inflitrated breast cancer signal organised immune response and predict survival ( Dr Karen Willard-Gallo - Université Libre de Bruxelles, Brussels, Belgium )
15 May 2013
How do we design trials that improve outcome?
Dr Lisa Carey - University of North Carolina, Chapel Hill, USA
How do we design trials that improve outcome? ( Dr Lisa Carey - University of North Carolina, Chapel Hill, USA )
15 May 2013
Breast cancer heterogeneity no barrier to predictive testing
Dr Michał Jarząb - Maria Skłodowska-Curie Institute of Oncology, Gliwice, Poland
Breast cancer heterogeneity no barrier to predictive testing ( Dr Michał Jarząb - Maria Skłodowska-Curie Institute of Oncology, Gliwice, Poland )
15 May 2013
Single cell sequencing techniques in early and late breast cancer
Dr Nicholas Navin - MD Anderson Cancer Center, Houston, TX, USA
Single cell sequencing techniques in early and late breast cancer ( Dr Nicholas Navin - MD Anderson Cancer Center, Houston, TX, USA )
15 May 2013
Measurement variation influences gene expression profiles of breast cancer
Dr Rosanna Lau - MD Anderson Cancer Center, Houston, TX, USA
Measurement variation influences gene expression profiles of breast cancer ( Dr Rosanna Lau - MD Anderson Cancer Center, Houston, TX, USA )
15 May 2013
The future of PI3K/AKT/mTOR inhibitors in breast cancer
Dr Sara Hurvitz - UCLA Santa Monica Hematology Oncology, USA
The future of PI3K/AKT/mTOR inhibitors in breast cancer ( Dr Sara Hurvitz - UCLA Santa Monica Hematology Oncology, USA )
15 May 2013
Extracellular matrix proteins of stem cell niches promote breast cancer metastas...
Dr Thordur Oskarsson - HI-STEM, Heidelberg, Germany
Extracellular matrix proteins of stem cell niches promote breast cancer metastasis ( Dr Thordur Oskarsson - HI-STEM, Heidelberg, Germany )
15 May 2013
Early effect of PI3K-Akt-mTOR blockade on in vitro 18F-FDG uptake in HER2 breas...
Dr Yanina Dockx - University of Antwerp, Edegem, Belgium
Early effect of PI3K-Akt-mTOR blockade on in vitro 18F-FDG uptake in HER2  breast cancer resistant to trastuzumab ( Dr Yanina Dockx - University of Antwerp, Edegem, Belgium )
15 May 2013
Update on the METABRIC consortium 2000 Breast Cancer Study
Prof Carlos Caldas - University of Cambridge, UK
Update on the METABRIC consortium 2000 Breast Cancer Study ( Prof Carlos Caldas - University of Cambridge, UK )
14 May 2013
The Cancer Genome Atlas (TCGA): comprehensive molecular portraits of breast canc...
Prof Charles Perou - University of North Carolina School of Medicine, USA
The Cancer Genome Atlas (TCGA): comprehensive molecular portraits of breast cancer ( Prof Charles Perou - University of North Carolina School of Medicine, USA )
14 May 2013
Genetic alterations in postmenopausal women with hormone receptor-positive, HER2...
Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium
Genetic alterations in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer ( Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
14 May 2013
Gene expression test distinguishes between breast cancer patients at high or low...
Prof Michael Gnant - Medical University of Vienna, Austria
Gene expression test distinguishes between breast cancer patients at high or low risk of late recurrence ( Prof Michael Gnant - Medical University of Vienna, Austria )
14 May 2013
Long-term effectiveness of SERMs for preventing breast cancer
Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Long-term effectiveness of SERMs for preventing breast cancer ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
14 May 2013